Duopharma net profit rises 15% in 1Q


Duopharma Biotech group managing director Leonard Ariff Abdul Shatar

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit rose 15.2% to RM20.29mil in the first quarter ended March 31 against RM17.61mil a year ago on higher sales.

The pharmaceutical group saw its revenue rise 11.7% to RM185.94mil from RM166.45mil a year prior. Its earnings per share for the quarter stood at 2.19 sen, compared with 1.90 sen last year.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Exsim Hospitality unit secures RM45mil contract to develop Summit Hotel USJ
Batu Kawan to acquire 47.7% stake in MKH for RM549.8mil, triggers takeover offer
Meta Bright acquires 70% stake in engineering firm for RM9.29mil
MR DIY 1Q net profit rises to RM192mil on higher revenue, better margins
VSTECS sees stronger FY26 momentum despite external headwinds
EMCC 1Q26 net profit surges 95.6% on stronger pawnbroking demand
AEON Credit raises additional RM550mil from RM5b sukuk wakalah programme
Bumi Armada unit signs Indonesia offshore PSC for Jalu block in Andaman Sea
Sunway Healthcare cautiously optimistic on outlook
Ringgit firmer against US dollar as stronger export performance lifts market sentiment

Others Also Read